Insider Transactions in Q3 2021 at E Ffector Therapeutics, Inc. (EFTR)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 25
2021
|
Stephen T Worland Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193,141
+20.36%
|
-
|
|
Aug 25
2021
|
Stephen T Worland Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
562,339
+29.08%
|
$5,623,390
$10.0 P/Share
|
|
Aug 25
2021
|
Alana B. Mc Nulty Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,768
+50.0%
|
-
|
|
Aug 25
2021
|
John W Smither Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,142
+50.0%
|
-
|
|
Aug 25
2021
|
Locust Walk Sponsor, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,511,250
+46.4%
|
-
|
|
Aug 25
2021
|
Brian M. Gallagher Jr. |
BUY
Grant, award, or other acquisition
|
Indirect |
4,822,114
+50.0%
|
-
|
|
Aug 25
2021
|
Elizabeth Bhatt |
BUY
Conversion of derivative security
|
Indirect |
9,047
+50.0%
|
-
|
|
Aug 25
2021
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,822,114
+31.44%
|
$48,221,140
$10.0 P/Share
|
|
Aug 25
2021
|
Christopher B Ehrlich |
BUY
Conversion of derivative security
|
Indirect |
143,202
+50.0%
|
-
|